Company Filing History:
Years Active: 2018-2020
Title: Rishi S Bhatt: Innovator in Blood-Brain Barrier Research
Introduction
Rishi S Bhatt is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in developing peptide compositions that can cross the blood-brain barrier. With a total of 3 patents to his name, Bhatt is recognized for his innovative approaches to addressing critical health challenges.
Latest Patents
Rishi S Bhatt's latest patents focus on blood-brain barrier permeable peptide compositions. One of his notable inventions involves peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody. These compositions are designed to bind to therapeutic and diagnostic biomarkers in the central nervous system, specifically targeting the amyloid-beta peptide biomarker associated with Alzheimer's disease. Another patent describes similar peptide compositions that contain variable antigen binding domains from camelid and/or shark heavy-chain only single-domain antibodies. Both inventions aim to enhance the delivery of therapeutic agents to the brain, which is crucial for treating neurodegenerative diseases.
Career Highlights
Rishi S Bhatt is currently associated with ICB International, Inc., where he continues to advance his research in peptide technology. His work has garnered attention for its potential impact on treating conditions that affect the central nervous system. Bhatt's innovative spirit and dedication to research have positioned him as a key figure in his field.
Collaborations
Rishi collaborates with his coworker, Ram S Bhatt, to further enhance their research efforts. Their combined expertise contributes to the development of groundbreaking solutions in biomedical science.
Conclusion
Rishi S Bhatt is a notable inventor whose work in blood-brain barrier research is paving the way for new therapeutic approaches. His contributions are vital in the ongoing fight against neurodegenerative diseases, and his innovative patents reflect his commitment to improving healthcare outcomes.